Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Pharm Sci. 2015 Jul 17;104(11):3681–3690. doi: 10.1002/jps.24573

Table 2.

The Number of Mice in Each Group Treated with Various OVA Formulations Showing Anti-OVA Antibodies at Day 29

Mouse Group IgG1 IgG2a IgG2b IgG2c IgG3 IgM
OVA 5/8 0/8 3/8 0/8 4/8 3/8
OVA + emulsified silicone oil 8/8 4/8 5/8 2/8 4/8 2/8
OVA + syringe-extracted silicone oil 7/8 1/8 3/8 0/8 6/8 0/8
OVA + alum 8/8 3/8 8/8 1/8 6/8 4/8